Description
Stanley T. Crooke explores the evolving landscape of anthracyclines, a class of chemotherapy agents renowned for their efficacy in treating various cancers. The book delves into their current applications, shedding light on advancements in their usage and understanding, particularly in the context of patient outcomes and drug resistance.
Through a detailed examination of ongoing research and clinical trials, Crooke highlights breakthroughs that promise to enhance the effectiveness of anthracyclines. He discusses modifications and novel formulations aimed at improving safety profiles and therapeutic efficacy, fostering a deeper appreciation for the drug's role in contemporary oncology.
The narrative weaves together scientific insights with practical implications, making complex concepts accessible to a broad audience. This expansive resource is essential for healthcare professionals, researchers, and anyone interested in the dynamic field of cancer treatment.
Through a detailed examination of ongoing research and clinical trials, Crooke highlights breakthroughs that promise to enhance the effectiveness of anthracyclines. He discusses modifications and novel formulations aimed at improving safety profiles and therapeutic efficacy, fostering a deeper appreciation for the drug's role in contemporary oncology.
The narrative weaves together scientific insights with practical implications, making complex concepts accessible to a broad audience. This expansive resource is essential for healthcare professionals, researchers, and anyone interested in the dynamic field of cancer treatment.
Book Details
Format
Hardcover
Pages
444 pages
Language
English
Published
Jan 1, 1980
Publisher
Academic Press
ISBN-10
0121977803
ISBN-13
9780121977801